Updates from World Health Organization here:
We are not saying GermXit® can cure or provide 100% protection from coronaviruses.
What we are saying is that:
GERMXIT® HAS SUCCESSFULLY PASSED EFFICACY TESTS AGAINST
HUMAN CORONAVIRUS, A1 H1N1 INFLUENZA VIRUS
Tests were conducted in March-April 2020, according to EN 14476 standard. Details are coming soon in “Test reports” section of our website.
TEA TREE OIL ANTIVIRAL EFFICACY / KEY DATA
2006 Carson et al :
Tobacco mosaic virus After 10 days the lesions were significantly lower in all TTO treatments
Herpes Simplex Virus TTO inhibited 50% of plaque formation at a concentration of 0.0009% for HSV type 1 (HSV-1) and 0.0008% for HSV-2, relative to controls
HSV-1 in Vero cells 1% TTO concentration inhibiting plaque formation completely and 0.1% TTO reducing plaque formation by approximately 10%. (Vero cells are isolated from kidney epithelial cells)
“The results of these studies indicate that TTO may act against enveloped and non-enveloped viruses, although the range of viruses tested to date is very limited.”
TTO inhibited 50% of plaque formation at concentrations of 0.0009% for HSV-1 and 0.0008% for HSV-2, relative to controls 
The minimum effective in vitro concentration to kill some viruses is 0.125% 
Air dispersion through a TTO treated filter can totally inactivate tested viruses at 15 minutes 
TTO at a concentration of 0.02% prevented tested viruses from entering the host cell which helps prevent viral replication 
GermXit® has also been tested and proven effective against a long list of pathogens, airborne and non-airborne.
It works by destroying the spore/cell membrane, inactivating the pathogen.
GermXit® is working 24/7 reducing the number of bacteria/microorganisms in the air AND on surfaces, removing the host cells and reducing risks of virus spreading.
If there is any risk of airborne infection outbreak, it’s always better to take preventive measures to reduce these risks to a minimum, be it common cold, influenza or a dangerous pathogen.
GermXit® provides protection by removing the hosts, that can spread the virus.
GermXit® has been proven efficient against the following pathogens:
S. aureus ATCC 6538 (Mahidol University, 2015)
S. choleraesuis ATCC 10708 (Mahidol University, 2015)
E. coli ATCC 25922 (Monash University, 2002)
E. coli ATCC 10536 (PSB Corporation, Singapore, 2003)
Staphylococcus aureus ATCC 6538 (PSB Corporation, Singapore, 2003)
Pseudomonas aeruginosa ATCC 15422 (PSB Corporation, Singapore, 2003)
Salmonella typhimurium ATCC 14028 (PSB Corporation, Singapore, 2003)
Legionella pneumophila ATCC 33152 (PSB Corporation, Singapore, 2003)
Total bacterial plate counts, including Legionella species bacteria(Micro Tech Laboratories, Victoria, 2000)
B. Anthracis (under specific conditions) (Agriculture Victorian Institute of Animal Science, Australia, 2001)
Candida albicans ATCC 2091